Dermal Filler Market By Type (Hyaluronic acid (HA), Calcium Hydroxylapatite (CaHA), Poly L lactic Acid, Others), By Gender (Male, Female), By Service Provider (Specialty and Dermatology Clinics, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Dermal Filler Market

Dermal filler is defined as a gel like substance, which is injected into the face to enhance shallow contours, plump thin lips, remove wrinkles, soften facial creases, and diminish the appearance of the scars. Hyaluronic acid is one of the most common types of dermal filler used among the population. Dermal filler is injected by the healthcare providers around the eyes, mouth, and nose. Dermal filler procedures aim to gain youthful appearance and enhance the facial features.

The factors that drive the growth of the global dermal filler market size include an increase in the prevalence of the geriatric population, technological advancements in dermal filler product, and surge in demand for anti-aging treatment. In addition, the rise in number of injectable fillers procedure in the female population, notably contributes toward the growth of the global market. According to the International Society of Aesthetic Plastic Surgery, in 2020, approximately 2.5 million hyaluronic acid procedure is conducted in the female population across the world. As per the same source, in 2020, approximately 1.3 million hyaluronic acid procedure is conducted in population of the age group between 40 to 54 years. This augments the need for dermal filler products among the geriatric population. Furthermore, market players focus on the manufacturing of advanced dermal filler for aesthetic solution. For instance, in February 2022, Merz Aesthetics, a medical aesthetics company announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection to improve moderate to severe loss of jawline contour in adults over the age of 21 years. Moreover, Galderma is a dermatologist and pharmaceutical company, received approval for two aesthetic products. Thus, increase in number of dermal filler industry to manufacture dermal filler products propels the growth of the market.

In addition, in May 2020, the Food & Drug Administration (FDA) announced the approval for Restylane kysse, a new hyaluronic acid (HA) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth. The FDA aims to enhance the availability of dermal filler product and increase the access to a wide range of dermal filler for consumers.

Moreover, rise in development of medical aesthetic industry and improvement in healthcare spending are anticipated to drive the growth of the dermal filler market. For instance, in 2021, McKinsey & Company, conducted a survey to analyze the use of dermal filler among different age group and income population. It was reported that, the population with annual income of more than $100,000 are the active users of dermal filler. In addition, the increase in the number of female population and rise in self-awareness among young population regarding the physical appearance led to the development of innovative technologies in the aesthetic sector, thereby propelling the growth of the market.

Moreover, the increase in the number of licensed medical centers is the key factor that boosts the growth of the dermal filler market analysis. The reason behind the increasing number of medical centers is attributed to surge in number of non-invasive aesthetic procedures such as dermal filler and botox. Furthermore, the rise in prevalence of skin damage and increase in geriatric female population, who are more vulnerable to wrinkle and facial line, propel the growth of the market. In addition, the rise in disposable income and increase in awareness regarding different facial aesthetic treatments among the female population fuel the dermal filler market trends.

The dermal filler market share is segmented on the basis of type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. The hyaluronic acid segment dominated the market in 2021, and this trend is expected to continue during the dermal filler market forecast period, owing to increase in number of hyaluronic acids-based dermal filler products, advancement in R&D activities in medical aesthetic industry, and rise in prevalence of early aging of the skin.

By gender, it is bifurcated into male and female. The female segment acquired the top position in the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in demand for dermal filler procedures, rapidly growing emphasis on personal aesthetics among females, and rise in number of female populations conducting minimal invasive aesthetic procedure.

As per service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The hospitals segment led the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in number of hospitals to conduct dermal filler procedures and rise in expenditure by governments to improve the healthcare industry.

North America accounted for a majority of the global dermal filler market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to a rise in prevalence of early aging of the skin due to external environmental factors, increase in the number of approvals for dermal filler product, the presence of dermal filler industry, and development in technology for dermal filler in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of approvals for aesthetic products, the rise in geriatric populations, growth in health care expenditures, and a rise in adoption of dermal filler product.

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global dermal filler market. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Non-essential surgical procedures were cancelled due to the pandemic. Dermal filler procedures are non-emergency procedures that significantly hampered revenue of aesthetic companies. In addition, sudden, sharp cut in a monthly income of the population is anticipated to have a negative impact on the dermal filler market.

Key Findings of The Study

By type, the hyaluronic acid segment was the highest contributor to the market in 2021.

By gender, the male segment was the highest contributor to the market in 2021.

By service provider, the hospitals segment dominated the market in 2021, and is expected to continue this trend during the forecast period.

By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period

Overview

The global dermal filler market was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as an aesthetic procedure, which is injected beneath the surface of the skin to add fullness & volume, smooth lines & soften creases, and increase the facial contours. It is widely used for facial aesthetic treatment. The different types of dermal filler are hyaluronic acid, calcium hydroxylapatite, polylactic acid, and polymethyl-methacrylate microspheres. It is used to enhance or fill the shallow areas on the face. In addition, this procedure is mostly used among population to reduce wrinkle under eyes.

The growth of the global dermal filler market is majorly driven by an alarming increase in demand for minimally invasive procedure; rise in government initiative for the advancement of dermal filler procedure; surge in the number of approvals for dermal filler' products; and a rise in adoption of hyaluronic acid. According to the journal of Dermatology & Mohs Surgery Institute, it was analyzed that dermal filler is one of the leading minimally invasive skin procedure, globally. For instance, in 2021, Deloitte, one of the leading professional services companies, reported that around 9.53% of hyaluronic acid is consumed in China. Thus, the increase in prevalence of hyaluronic acid boosts the demand for dermal filler procedure.

Moreover, in 2021, the U.S. Food and drug Administration (FDA) announced the approval of RHA Redensity Dermal Filler, which is used for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in the adults above the age of 22. Furthermore, in 2021, Revance Therapeutics, Inc., a biotechnology company, presented data on the effectiveness and safety of the RHA collection of dermal filler. It is one of the latest advances in hyaluronic acid filler technology, which is used for the treatment of moderate-to-severe nasolabial folds in darker skin color. The increase in advancements in dermal filler technology aims to obtain long-lasting, and effective results. Thus, advancements in technology for advanced dermal filler products in emerging nations are expected to propel the growth of the market.

The increase in government support for aesthetic procedure and surge in demand for aesthetic procedure are the major factors that drive the global dermal filler market. For instance, in February 2022, the GOV.UK announced to introduce a licensing regime for non-surgical cosmetic procedures such as dermal filler and Botox. This step aims to protect the public against botch fillers and botox. In addition, increase in the number of anti-aging treatment significantly contributes toward the market growth. Rise in demand for aesthetic looks among young population acts a key driving force for the expansion of the global market.

However, the high cost associated with dermal filler procedure is anticipated to hinder the market growth. Increase in prevalence of early skin aging, surge the need for hyaluronic acid and drive the growth of the market. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the dermal filler market.

The dermal filler market is segmented into type, gender, service provider, and region. By type, the market is categorized into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. By gender, it is bifurcated into male and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global dermal filler market are include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermal filler market analysis from 2021 to 2031 to identify the prevailing dermal filler market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the dermal filler market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global dermal filler market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Vital Esthetique Laboratorie

Scope of Dermal Filler Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

3.7.Patent Landscape

4.1 Overview

4.1.1 Market size and forecast

4.2 Hyaluronic acid (HA)

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.2.4 Hyaluronic acid (HA) Dermal Filler Market by Age group

4.2.4.1 13 to 39 Market size and forecast, by region

4.2.4.2 40 to 54 Market size and forecast, by region

4.2.4.3 55 to 69 Market size and forecast, by region

4.3 Calcium Hydroxylapatite (CaHA)

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Poly L lactic Acid

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Others

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Male

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Female

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Specialty and Dermatology Clinics

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Hospitals

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Others

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Type

7.2.2.1 North America Hyaluronic acid (HA) Dermal Filler Market by Age group

7.2.3 North America Market size and forecast, by Gender

7.2.4 North America Market size and forecast, by Service Provider

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Type

7.2.5.1.2 Market size and forecast, by Gender

7.2.5.1.3 Market size and forecast, by Service Provider

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Type

7.2.5.2.2 Market size and forecast, by Gender

7.2.5.2.3 Market size and forecast, by Service Provider

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Type

7.2.5.3.2 Market size and forecast, by Gender

7.2.5.3.3 Market size and forecast, by Service Provider

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Type

7.3.2.1 Europe Hyaluronic acid (HA) Dermal Filler Market by Age group

7.3.3 Europe Market size and forecast, by Gender

7.3.4 Europe Market size and forecast, by Service Provider

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by Type

7.3.5.1.2 Market size and forecast, by Gender

7.3.5.1.3 Market size and forecast, by Service Provider

7.3.5.2 France

7.3.5.2.1 Market size and forecast, by Type

7.3.5.2.2 Market size and forecast, by Gender

7.3.5.2.3 Market size and forecast, by Service Provider

7.3.5.3 UK

7.3.5.3.1 Market size and forecast, by Type

7.3.5.3.2 Market size and forecast, by Gender

7.3.5.3.3 Market size and forecast, by Service Provider

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by Type

7.3.5.4.2 Market size and forecast, by Gender

7.3.5.4.3 Market size and forecast, by Service Provider

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by Type

7.3.5.5.2 Market size and forecast, by Gender

7.3.5.5.3 Market size and forecast, by Service Provider

7.3.5.6 Rest of Europe

7.3.5.6.1 Market size and forecast, by Type

7.3.5.6.2 Market size and forecast, by Gender

7.3.5.6.3 Market size and forecast, by Service Provider

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Type

7.4.2.1 Asia-Pacific Hyaluronic acid (HA) Dermal Filler Market by Age group

7.4.3 Asia-Pacific Market size and forecast, by Gender

7.4.4 Asia-Pacific Market size and forecast, by Service Provider

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 China

7.4.5.1.1 Market size and forecast, by Type

7.4.5.1.2 Market size and forecast, by Gender

7.4.5.1.3 Market size and forecast, by Service Provider

7.4.5.2 Japan

7.4.5.2.1 Market size and forecast, by Type

7.4.5.2.2 Market size and forecast, by Gender

7.4.5.2.3 Market size and forecast, by Service Provider

7.4.5.3 India

7.4.5.3.1 Market size and forecast, by Type

7.4.5.3.2 Market size and forecast, by Gender

7.4.5.3.3 Market size and forecast, by Service Provider

7.4.5.4 Australia

7.4.5.4.1 Market size and forecast, by Type

7.4.5.4.2 Market size and forecast, by Gender

7.4.5.4.3 Market size and forecast, by Service Provider

7.4.5.5 Rest of Asia-Pacific

7.4.5.5.1 Market size and forecast, by Type

7.4.5.5.2 Market size and forecast, by Gender

7.4.5.5.3 Market size and forecast, by Service Provider

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Type

7.5.2.1 LAMEA Hyaluronic acid (HA) Dermal Filler Market by Age group

7.5.3 LAMEA Market size and forecast, by Gender

7.5.4 LAMEA Market size and forecast, by Service Provider

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by Type

7.5.5.1.2 Market size and forecast, by Gender

7.5.5.1.3 Market size and forecast, by Service Provider

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by Type

7.5.5.2.2 Market size and forecast, by Gender

7.5.5.2.3 Market size and forecast, by Service Provider

7.5.5.3 Colombia

7.5.5.3.1 Market size and forecast, by Type

7.5.5.3.2 Market size and forecast, by Gender

7.5.5.3.3 Market size and forecast, by Service Provider

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Market size and forecast, by Type

7.5.5.4.2 Market size and forecast, by Gender

7.5.5.4.3 Market size and forecast, by Service Provider

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 AbbVie Laboratories

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 Bioxis pharmaceutical

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Cutera Inc

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Elan aesthetics Inc

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Galderma SA

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 Merz Pharma GmbH and Co. KGaA

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Revance Therapeutics

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Sinclair Pharma

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Teoxane Laboratories

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Vital Esthetique Laboratories

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 2. DERMAL FILLER MARKET, FOR HYALURONIC ACID (HA), BY REGION, 2021-2031 ($MILLION)

TABLE 3. DERMAL FILLER MARKET FOR HYALURONIC ACID (HA), BY COUNTRY, 2021-2031 ($MILLION)

TABLE 4. GLOBAL HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)

TABLE 5. DERMAL FILLER MARKET, FOR 13 TO 39, BY REGION, 2021-2031 ($MILLION)

TABLE 6. DERMAL FILLER MARKET, FOR 40 TO 54, BY REGION, 2021-2031 ($MILLION)

TABLE 7. DERMAL FILLER MARKET, FOR 55 TO 69, BY REGION, 2021-2031 ($MILLION)

TABLE 8. DERMAL FILLER MARKET, FOR CALCIUM HYDROXYLAPATITE (CAHA), BY REGION, 2021-2031 ($MILLION)

TABLE 9. DERMAL FILLER MARKET FOR CALCIUM HYDROXYLAPATITE (CAHA), BY COUNTRY, 2021-2031 ($MILLION)

TABLE 10. DERMAL FILLER MARKET, FOR POLY L LACTIC ACID, BY REGION, 2021-2031 ($MILLION)

TABLE 11. DERMAL FILLER MARKET FOR POLY L LACTIC ACID, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 12. DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 13. DERMAL FILLER MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 14. GLOBAL DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 15. DERMAL FILLER MARKET, FOR MALE, BY REGION, 2021-2031 ($MILLION)

TABLE 16. DERMAL FILLER MARKET FOR MALE, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 17. DERMAL FILLER MARKET, FOR FEMALE, BY REGION, 2021-2031 ($MILLION)

TABLE 18. DERMAL FILLER MARKET FOR FEMALE, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 19. GLOBAL DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 20. DERMAL FILLER MARKET, FOR SPECIALTY AND DERMATOLOGY CLINICS, BY REGION, 2021-2031 ($MILLION)

TABLE 21. DERMAL FILLER MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 22. DERMAL FILLER MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 23. DERMAL FILLER MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 24. DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 25. DERMAL FILLER MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 26. DERMAL FILLER MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 27. NORTH AMERICA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 28. NORTH AMERICA HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)

TABLE 29. NORTH AMERICA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 30. NORTH AMERICA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 31. NORTH AMERICA DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 32. U.S. DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 33. U.S. DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 34. U.S. DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 35. CANADA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 36. CANADA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 37. CANADA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 38. MEXICO DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 39. MEXICO DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 40. MEXICO DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 41. EUROPE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 42. EUROPE HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)

TABLE 43. EUROPE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 44. EUROPE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 45. EUROPE DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 46. GERMANY DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 47. GERMANY DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 48. GERMANY DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 49. FRANCE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 50. FRANCE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 51. FRANCE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 52. UK DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 53. UK DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 54. UK DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 55. ITALY DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 56. ITALY DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 57. ITALY DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 58. SPAIN DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 59. SPAIN DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 60. SPAIN DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 61. REST OF EUROPE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 62. REST OF EUROPE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 63. REST OF EUROPE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 64. ASIA-PACIFIC DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 65. ASIA-PACIFIC HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)

TABLE 66. ASIA-PACIFIC DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 67. ASIA-PACIFIC DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 68. ASIA-PACIFIC DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 69. CHINA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 70. CHINA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 71. CHINA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 72. JAPAN DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 73. JAPAN DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 74. JAPAN DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 75. INDIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 76. INDIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 77. INDIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 78. AUSTRALIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 79. AUSTRALIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 80. AUSTRALIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 81. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 82. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 83. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 84. LAMEA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 85. LAMEA HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)

TABLE 86. LAMEA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 87. LAMEA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 88. LAMEA DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 89. BRAZIL DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 90. BRAZIL DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 91. BRAZIL DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 92. SAUDI ARABIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 93. SAUDI ARABIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 94. SAUDI ARABIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 95. COLOMBIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 96. COLOMBIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 97. COLOMBIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 98. REST OF LAMEA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 99. REST OF LAMEA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)

TABLE 100. REST OF LAMEA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)

TABLE 101.ABBVIE LABORATORIES: COMPANY SNAPSHOT

TABLE 102.ABBVIE LABORATORIES: OPERATING SEGMENTS

TABLE 103.ABBVIE LABORATORIES: PRODUCT PORTFOLIO

TABLE 104.ABBVIE LABORATORIES: NET SALES,

TABLE 105.ABBVIE LABORATORIES: KEY STRATERGIES

TABLE 106.BIOXIS PHARMACEUTICAL: COMPANY SNAPSHOT

TABLE 107.BIOXIS PHARMACEUTICAL: OPERATING SEGMENTS

TABLE 108.BIOXIS PHARMACEUTICAL: PRODUCT PORTFOLIO

TABLE 109.BIOXIS PHARMACEUTICAL: NET SALES,

TABLE 110.BIOXIS PHARMACEUTICAL: KEY STRATERGIES

TABLE 111.CUTERA INC: COMPANY SNAPSHOT

TABLE 112.CUTERA INC: OPERATING SEGMENTS

TABLE 113.CUTERA INC: PRODUCT PORTFOLIO

TABLE 114.CUTERA INC: NET SALES,

TABLE 115.CUTERA INC: KEY STRATERGIES

TABLE 116.ELAN AESTHETICS INC: COMPANY SNAPSHOT

TABLE 117.ELAN AESTHETICS INC: OPERATING SEGMENTS

TABLE 118.ELAN AESTHETICS INC: PRODUCT PORTFOLIO

TABLE 119.ELAN AESTHETICS INC: NET SALES,

TABLE 120.ELAN AESTHETICS INC: KEY STRATERGIES

TABLE 121.GALDERMA SA: COMPANY SNAPSHOT

TABLE 122.GALDERMA SA: OPERATING SEGMENTS

TABLE 123.GALDERMA SA: PRODUCT PORTFOLIO

TABLE 124.GALDERMA SA: NET SALES,

TABLE 125.GALDERMA SA: KEY STRATERGIES

TABLE 126.MERZ PHARMA GMBH AND CO. KGAA: COMPANY SNAPSHOT

TABLE 127.MERZ PHARMA GMBH AND CO. KGAA: OPERATING SEGMENTS

TABLE 128.MERZ PHARMA GMBH AND CO. KGAA: PRODUCT PORTFOLIO

TABLE 129.MERZ PHARMA GMBH AND CO. KGAA: NET SALES,

TABLE 130.MERZ PHARMA GMBH AND CO. KGAA: KEY STRATERGIES

TABLE 131.REVANCE THERAPEUTICS: COMPANY SNAPSHOT

TABLE 132.REVANCE THERAPEUTICS: OPERATING SEGMENTS

TABLE 133.REVANCE THERAPEUTICS: PRODUCT PORTFOLIO

TABLE 134.REVANCE THERAPEUTICS: NET SALES,

TABLE 135.REVANCE THERAPEUTICS: KEY STRATERGIES

TABLE 136.SINCLAIR PHARMA: COMPANY SNAPSHOT

TABLE 137.SINCLAIR PHARMA: OPERATING SEGMENTS

TABLE 138.SINCLAIR PHARMA: PRODUCT PORTFOLIO

TABLE 139.SINCLAIR PHARMA: NET SALES,

TABLE 140.SINCLAIR PHARMA: KEY STRATERGIES

TABLE 141.TEOXANE LABORATORIES: COMPANY SNAPSHOT

TABLE 142.TEOXANE LABORATORIES: OPERATING SEGMENTS

TABLE 143.TEOXANE LABORATORIES: PRODUCT PORTFOLIO

TABLE 144.TEOXANE LABORATORIES: NET SALES,

TABLE 145.TEOXANE LABORATORIES: KEY STRATERGIES

TABLE 146.VITAL ESTHETIQUE LABORATORIES: COMPANY SNAPSHOT

TABLE 147.VITAL ESTHETIQUE LABORATORIES: OPERATING SEGMENTS

TABLE 148.VITAL ESTHETIQUE LABORATORIES: PRODUCT PORTFOLIO

TABLE 149.VITAL ESTHETIQUE LABORATORIES: NET SALES,

TABLE 150.VITAL ESTHETIQUE LABORATORIES: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.DERMAL FILLER MARKET SEGMENTATION

FIGURE 2.DERMAL FILLER MARKET,2021-2031

FIGURE 3.DERMAL FILLER MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.DERMAL FILLER MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.PATENT ANALYSIS BY COMPANY

FIGURE 13.PATENT ANALYSIS BY COUNTRY

FIGURE 14.DERMAL FILLER MARKET,BY TYPE,2021(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF HYALURONIC ACID (HA) DERMAL FILLER MARKET,2021-2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CALCIUM HYDROXYLAPATITE (CAHA) DERMAL FILLER MARKET,2021-2031(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF POLY L LACTIC ACID DERMAL FILLER MARKET,2021-2031(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS DERMAL FILLER MARKET,2021-2031(%)

FIGURE 19.DERMAL FILLER MARKET,BY GENDER,2021(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MALE DERMAL FILLER MARKET,2021-2031(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF FEMALE DERMAL FILLER MARKET,2021-2031(%)

FIGURE 22.DERMAL FILLER MARKET,BY SERVICE PROVIDER,2021(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF SPECIALTY AND DERMATOLOGY CLINICS DERMAL FILLER MARKET,2021-2031(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOSPITALS DERMAL FILLER MARKET,2021-2031(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS DERMAL FILLER MARKET,2021-2031(%)

FIGURE 26.DERMAL FILLER MARKET BY REGION,2021

FIGURE 27.U.S. DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 28.CANADA DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 29.MEXICO DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 30.GERMANY DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 31.FRANCE DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 32.UK DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 33.ITALY DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 34.SPAIN DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 35.REST OF EUROPE DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 36.CHINA DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 37.JAPAN DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 38.INDIA DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 39.AUSTRALIA DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 40.REST OF ASIA-PACIFIC DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 41.BRAZIL DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 42.SAUDI ARABIA DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 43.COLOMBIA DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 44.REST OF LAMEA DERMAL FILLER MARKET,2021-2031($MILLION)

FIGURE 45. TOP WINNING STRATEGIES, BY YEAR

FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 49.COMPETITIVE DASHBOARD

FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 51.ABBVIE LABORATORIES.: NET SALES ,($MILLION)

FIGURE 52.BIOXIS PHARMACEUTICAL.: NET SALES ,($MILLION)

FIGURE 53.CUTERA INC.: NET SALES ,($MILLION)

FIGURE 54.ELAN AESTHETICS INC.: NET SALES ,($MILLION)

FIGURE 55.GALDERMA SA.: NET SALES ,($MILLION)

FIGURE 56.MERZ PHARMA GMBH AND CO. KGAA.: NET SALES ,($MILLION)

FIGURE 57.REVANCE THERAPEUTICS.: NET SALES ,($MILLION)

FIGURE 58.SINCLAIR PHARMA.: NET SALES ,($MILLION)

FIGURE 59.TEOXANE LABORATORIES.: NET SALES ,($MILLION)

FIGURE 60.VITAL ESTHETIQUE LABORATORIES.: NET SALES ,($MILLION